MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

ATRC — AtriCure, Inc.

Nasdaq

AtriCure, Inc.

Back to Screener
$55.14
+1.55(+2.89%)
O
52.51
H
55.25
L
52.00
V
1.62M
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About ATRC

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateAug 5, 2005
Employees1,350
Stock ExchangeNasdaq
Ticker SymbolATRC

Key Financial Statistics

Market Cap$2.97B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$25.36 - $61.70
52-Week Avg Volume791.0K
VWAP$54.19
Transactions23,308
Total Recorded Bars5,324 days